Hyperkinetická porucha patří k nejčastějším příčinám psychiatrické léčby u dětí. Diagnostická kritéria pro hyperkinetické poruchy podle ICD-10 se liší od kritérií DSM- IV pro ADHD. V důsledku těchto rozdílů je prevalence těchto poruch rozdílná v USA a v Evropě. Kritéria DSM-IV jsou „měkčí“ a zachycují širší část populace. V souvislosti s předpokládanou etiologií ADHD jsou zkoumány kandidátní geny. Výsledky ukazují na významnou roli dopaminergního a noradrenergního systému v patogenezi hyperkinetických poruch/ADHD. Strattera (atomoxetin) je nový noradrenergní preparát schválený pro léčbu ADHD v České republice od dubna 2007.
- Keywords
- Strattera,
- MeSH
- Child MeSH
- Dopamine genetics secretion MeSH
- Epidemiologic Studies MeSH
- Drug Therapy methods MeSH
- Attention Deficit Disorder with Hyperactivity etiology drug therapy therapy MeSH
- Hyperkinesis diagnosis etiology therapy MeSH
- Humans MeSH
- Methylphenidate administration & dosage pharmacology therapeutic use MeSH
- Drug-Related Side Effects and Adverse Reactions MeSH
- Child, Preschool MeSH
- Prevalence MeSH
- Propylamines administration & dosage pharmacology therapeutic use MeSH
- Risk Factors MeSH
- Family psychology MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Child, Preschool MeSH
- Publication type
- Randomized Controlled Trial MeSH
- MeSH
- Algorithms MeSH
- Child MeSH
- Drug Therapy methods standards MeSH
- Attention Deficit Disorder with Hyperactivity diagnosis drug therapy therapy MeSH
- Hyperkinesis diagnosis drug therapy therapy MeSH
- Comorbidity MeSH
- Humans MeSH
- Evidence-Based Medicine methods standards MeSH
- Psychotherapy methods standards MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Practice Guideline MeSH
- MeSH
- Diagnostic Imaging methods MeSH
- Drug Therapy methods MeSH
- Attention Deficit Disorder with Hyperactivity diagnosis etiology therapy MeSH
- Hyperkinesis diagnosis etiology therapy MeSH
- Neurotransmitter Agents physiology genetics MeSH
- Models, Theoretical MeSH
- Child Rearing MeSH
- Publication type
- Review MeSH
Sdělení podává přehled nejdůležitějších biologických poznatků ve vztahu k etiopatogenezi hyperkinetické poruchy (ADHD) s ohledem na používanou farmakoterapii.
The most relevant biological knowledge related to the etiopathogenesis of hyperkinetic disorder (Attention Deficit Hyperactivity Disorder – ADHD) is reviewed in relation to available drugs.
- MeSH
- Amphetamine therapeutic use MeSH
- Hyperkinesis diagnosis drug therapy MeSH
- Disruptive, Impulse Control, and Conduct Disorders diagnosis drug therapy MeSH
- Carbamazepine therapeutic use MeSH
- Humans MeSH
- Attention Deficit and Disruptive Behavior Disorders diagnosis drug therapy MeSH
- Psychopharmacology methods MeSH
- Risperidone therapeutic use MeSH
- Check Tag
- Humans MeSH
- MeSH
- Antipsychotic Agents administration & dosage adverse effects therapeutic use MeSH
- Bipolar Disorder diagnosis MeSH
- Diagnosis, Differential MeSH
- Child MeSH
- Research Support as Topic MeSH
- Attention Deficit Disorder with Hyperactivity diagnosis MeSH
- Hyperkinesis diagnosis MeSH
- Drug Therapy, Combination MeSH
- Humans MeSH
- Signs and Symptoms MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Review MeSH
Práce představuje současný psychologický přístup k dětem s ADHD/ADD, který je charakterizován několika tendencemi: 1. k diagnóze postačuje typické chování 2. poruchy chování jsou často chápány jako varianta chování v rámci normálního rozložení 3. vedle specifických psychoterapeutických metod nabývají na významu výchovné postupy uplatňované u dětí bez specifických poruch chování 4. zvyšuje se význam rodičů jako nejvýznamnějších preventistů a -terapeutů- ADHD.
The article introduces present psychological approach to children with ADHD/ADD, which is characterised by several tendencies: 1. Typical behaviour is sufficient for diagnosis. 2. Behavioural disorders are considered as a variation of behaviour within normal distribution. 3. Besides specific psychotherapeutic methods, educational methods gain an importance in children without specific disorders of behaviour. 4. The importance of parents is increased as the most important preventive persons and -therapists- of ADHD.
- MeSH
- Activities of Daily Living MeSH
- Child MeSH
- Attention Deficit Disorder with Hyperactivity diagnosis drug therapy prevention & control MeSH
- Hyperkinesis diagnosis drug therapy prevention & control MeSH
- Humans MeSH
- Conduct Disorder diagnosis drug therapy prevention & control MeSH
- Psychotherapy methods MeSH
- Person-Centered Psychotherapy MeSH
- Child Rearing MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Review MeSH
- MeSH
- Alleles MeSH
- Child MeSH
- Research Support as Topic MeSH
- Genotype methods MeSH
- Hyperkinesis diagnosis genetics MeSH
- Interleukin-6 genetics MeSH
- Humans MeSH
- Adolescent MeSH
- Polymorphism, Genetic MeSH
- Receptors, Dopamine D2 genetics MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Publication type
- Review MeSH
- Comparative Study MeSH
- MeSH
- Central Nervous System pathology growth & development MeSH
- Child MeSH
- Adult MeSH
- Attention Deficit Disorder with Hyperactivity diagnosis genetics therapy MeSH
- Hyperkinesis diagnosis etiology therapy MeSH
- Humans MeSH
- Hypoxia, Brain MeSH
- Neurotransmitter Agents MeSH
- Infant, Newborn MeSH
- Psychotropic Drugs therapeutic use MeSH
- Risk Factors MeSH
- Pregnancy MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Infant, Newborn MeSH
- Pregnancy MeSH
- Female MeSH
